Skip to content

Role of Ayurvedic drug in the form of churna in management of uterine disorder

EFFICACY OF PUTRANJEEVAK BEEJA CHURNA IN VANDHYATVA W S R TO THIN ENDOMETRIUM- A RANDOMISED CONTROL CLINICAL TRIAL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038724
Enrollment
20
Registered
2021-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N858- Other specified noninflammatory disorders of uterus

Interventions

None listed

Sponsors

Kahers Shri BMK Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Infertile female patients between the age group 20 to 40 yrs Sonographically diagnosed cases of Endometrial thickness Patients having Regular menstruation

Exclusion criteria

Exclusion criteria: k/c/o uterine growths, fibroids and malignancy k/c/o Venereal diseases k/c/o congenital abnormality of reproductive system

Design outcomes

Primary

MeasureTime frame
Objective Trans-vaginal sonography ET on 12th day of Menstrual cycle Ovulation on day 12th 14th 16th of Menstrual cycle Subjective Parameters Duration of bleeding Interval between two cycles Number of pads used per cycle Dysmenorrhea Clots Timepoint: Objective Trans-vaginal sonography ET on 12th day of Menstrual cycle Ovulation on day 12th 14th 16th of Menstrual cycle Subjective Parameters Duration of bleeding Interval between two cycles Number of pads used per cycle Dysmenorrhea Clots

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Kashvva V Hiremath

Kahers shri BM kankanwadi ayurvedic mahavidyakaya

drkvhiremath@gmail.com9448945687

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026